Table 2.
Characteristics of carbapenem resistant isolates
| Isolates | MIC (μg/ml) | AmpC Overproduction | blaVIM | oprD Mutation | |||||
|---|---|---|---|---|---|---|---|---|---|
| CAZ* | CAZ-COL | IMI | IMI-COL | MEM | MEM-COL | ||||
| P1-1 | 32 | 32 | 32 | 16 | 1 | 1 | − | − | 1.N.D† |
| P1-2 | 8 | 2 | 16 | 16 | 16 | 16 | + | − | 1.N.D |
| P1-3 | 8 | 8 | 16 | 16 | 16 | 16 | − | + | 6.N.D |
| P1-4 | 16 | 16 | 8 | 8 | 1 | 1 | − | − | 12.N.D |
| P1-7 | 256 | 256 | 256 | 256 | 128 | 128 | − | − | Not-D‡ |
| P1-8 | 2 | 2 | 16 | 8 | 8 | 8 | − | + | 18.N.D |
| P1-9 | 256 | 256 | 512 | 256 | 256 | 256 | − | − | Not-D |
| P1-10 | 256 | 256 | 32 | 16 | 8 | 1 | + | + | 5.N.D |
| P3-2 | 32 | 32 | 32 | 16 | 8 | 1 | + | − | 4.N.D |
| P3-5 | 2 | 2 | 16 | 1 | 1 | 1 | + | − | 11.N.D |
| P14-1 | 32 | 16 | 32 | 8 | 8 | 1 | + | + | 1.N.D |
| P14-2 | 2 | 2 | 8 | 1 | 1 | 1 | + | + | 7.N.D |
| P17-9 | 2 | 2 | 8 | 1 | 1 | 1 | + | − | 1.N.D |
| P17-10 | 2 | 2 | 8 | 1 | 1 | 1 | + | − | 6.N.D |
*
CAZ, Ceftazidime; CAZ-COL, Ceftazidime-Cloxacillin; IMI, Imipenem; IMI-COL, Imipenem-Cloxacillin; MEM, Meropenem; MEM-COL, Meropenem - Cloxacillin
†
Nucleotide Deletion,
‡
Not Determined